8- The Michigan Daily - SPORTSMonday - Monday, February 28, 1994
HERRINGTON
Continued from page 3
the fact that CBS wanted to show
the "good stuff' in prime time,
Turner's cable channel was forced
to cut to commercials whenever
anyone expected to finish higher
than 10th was performing.
So rather than show half-day
old events, TNT showed one and
a half-day old events.
I guess if the competition at
the Games had at least been any
good, it might have made up for
all of television's shortcomings.
Yet aside from Dan Jansen
finally winning a gold medal,
even the American competitors
were pretty boring.
Just because your name is
Picabo doesn't make you the next
Mary Lou Retton.
By the end of the Games I was
once again longing for the links.
Sadly, the Winter Olympics
seemed to make this one of the
most boring breaks I've ever had,
even for Connecticut standards.
I thought it couldn't get much
worse than last year when I had
my wisdom teeth pulled, but
wonders never cease.
Except in Lillehammer.
Rawlinson Photography
Presents:M
$1.00
A Bridal Faire
Wednesday, March 2, 1994
6:00 P.M.
At the
The Mayflower Meeting House -
455 South Main Street -;Plymouth, MI 48170 " .
Tickets are $3.00 in advance $4.00 at the door /
* Fashion Show \
" Exhibits
" Prizes. .
Free Engagement po.ra.t of all Wedding Couples in Attendance-.
Call for Ticket information: 453-8872_
oSU
Continued from page 4
erts said. "For some reason she has
found her niche. That is the kind of
performance we need. We need her to
be a leader and to put up numbers like
that."
Wolverine point guard Jennifer
Kiefer also came through. She made
all five of her shots, including three
treys, while collecting three assists
and three steals.
"She's done a great job," Ohio
State point guard Alysiah Bond said.
"She is very poised, very confident.
She did all the things she supposed to
do to help her team."
But while the two guards matched
Smith in points, they could not equal
the Buckeyes' ability to draw the foul.
Smith went to the free-throw line 15
times with her aggressive movement
to the hole - putting center Jennifer
Brzezinski and forward Silver
Shellman to the bench early with foul
trouble.
"Today the ref actually called some
fouls," Smith said. "That helps when
they get in foul trouble. You can be
more aggressive when they do call."
A favorable call for Smith proved
to be one of the turning points of the
contest. After a Johnson bucket cut
the Buckeyes lead to 59-56 at 6:47 of
the second half, Smith drew a block-
ing foul on freshman Jennifer Kiefer
while tossing in a sprawling jumper.
Smith converted the three-point play
for a 62-56 lead and Michigan never
came closer.
"They were protecting Katie Smith
all night long," Roberts said. "I think
this game was taken away from us. It
took three not so good officials and
12,000 fans to do it. We don't get any
respect at all in the Big Ten."
By BRENT McINTOSH
DAILY BASKETBALL WRITER
Isn't setting records supposed to
be satisfying? Isn't it supposed to be
fulfilling?
Well, the Michigan women's bas-
ketball team has set several records
this -year thanks to much-improved
three-point shooting, but coach Trish
Roberts isn't exactly happy about it.
The Wolverines have made more
three-pointers (94) this season than
any other season. They have also set
the Michigan single-game record for
threes attempted by a team (20), made
by a team (nine), attempted by an
individual (10 by freshman guard
Amy Johnson), and made by an indi-
vidual (five by freshman guard Jen-
nifer Kiefer).
Along the way, Kiefer has grabbed
the distinction of being Michigan's
most accurate three-point shooter
ever, at .452, and Johnson is already
third on the list for career three-point-
ers made at 43, despite being a rookie.
These are impressive stats, but
Roberts would trade them all for some
solid post play.
"Right now our perimeter players
are a little more confident and our
inside game is not that strong," Rob-
erts said. "We traditionally don't post
up very strong inside - we really
don't have an inside game, so our
outside players feel a little more con-
fident.
"Most times when they pass the
ball inside, they get turnovers. They
don't have confidence in (the team's)
inside game. You'll notice that a lot
of our offense is geared towards the
jump shots."
THAT COLUMBUS MYSTIQUE: The
Wolverines managed' once again to
lose in St. John Arena, this time 80-
73, February 20, keeping the number
of Michigan women's basketball vic-
tories in that venue at zero.
The hostile crowd they faced in
Columbus numbered 12,003 - the
largest crowd before which any Wol-
verine women's hoop squad has ever
played.
MICHIGAN VS. IOWA, IOWA vS. THE
WORLD: Michigan's 65-55 loss yes-
terday marked its 17th consecutive
loss to Iowa. The Wolverines haven't
triumphed since a 58-56 victory Janu-
ary 19, 1986 - when current fresh-
man guards Kiefer and Mekisha Ross
were 10 years old.
Despite sweeping Michigan, the
Hawkeyes have lost five times this year
and dropped to No. 14 in the AP poll.
This is the first time since the 1990-91
season that coach Vivian Stringer's
team hasn't been in the top ten.
"We've been struggling all year,"
Stringer said. "We've been up and
down. We've played good in games
against big people, and we struggle,
as a rule, against lesser opponents.
It's been a struggle."
A RAINBOW OF SOCKs: The Wol-
verines have recently broken out blue
socks, a fashion statement in contrast
to the white they had worn earlier in
the season. Iowa's players wore
mostly white socks, but a couple of
players, including Hawkeye star
Necole Tunsil, showed up in black
socks, a la Michigan's Fab Five.
BASKETBALL NOTEBOOK:
Roberts finds record-
setting ungratfying
IOWA
Continued from page 4
gan lost by only nine points in its first
meeting with the Gophers (7-6,16-6),
Jan. 30.
"Last week we really expected
that we could do a better job against
Minnesota," Michigan assistantcoach
Kathy LaBarge Miles said. "Up there
we lost by nine and we felt that we
played a terrible game."
Ten minutes into the game, Min-
nesota lead 16-6. Two Michigan
timeouts failed to ignite the players,
who trailed 39-21 at the half.
"For some reason we weren't re-
ally ready to play," LaBarge Miles
said. "We played like seven individu-
als. Not that anybody was trying to do
it all themselves, but just that nobody
really seemed to be in synch with
each other."
The Gophers played an intense
first half, during which they snatched
14 of their 21 steals.
"We forced a lot of turnovers in
the first half with our pressure," Min-
nesota coach Linda Hill-MacDonald
said. "(Michigan) was rushing its
passes a little bit."
Like Iowa, almost all of
Minnesota's players contributed to
the scoring. Shudlick, who ranks third
in the country in scoring, led Minne-
sota with 25 points. Pearson and
Loeblein each had 18.
"This is not a selfish team, not in
the least," Hill-MacDonald said.
"They don't care who does the scor-
ing; what matters is what the
scoreboard says in the end."
For the Wolverines, Johnson had
another big night, bringing in 25 points.
In spite of another disappointing
weekend for Michigan women's bas-
ketball, the team remains upbeat.
"We're looking at it like this: we've
got four games left. Our record is 0-0,"
said team captian Shimmy Gray. "We
want to be 4-0 at the end of the season.
That's how we're looking at it."
"
0
The University Unions
need YOU
to participate in Focus Groups
regarding
Meeting Room & Food Service/Catering.
Policies
U 3
Department of Recreational
Sports
INTRAMURAL
SPORTS PROGRAM
North Campus Commons
in the Boulevard Room
Thursday, March 3 2pm - 3pm
Wednesday, March 9 6pm - 7pm
MOSCOW ST. PETERSBURG MOSCOW
INTERNATIONAL PROGRAMS
BOSTON'b
UNIVERSITY
Egz
Michigan League Tuesday, March 1 10am -11am
in Room D, third floor Thursday, March 3 6pm - 7pm
Michigan Union
in the Welker Room
Friday, March 4 2pm - 3pm
Monday, March 7 6pm - 7pm
Tuesday, March 8 10am - 11am
MINI-SOCCER
Entries Taken: Tuesday 3/1
(Instant Scheduling)
11:00 a.m. - 4:30 p.m.
IMSB Main Lobby
Play Begins: Thursday 3/3
For Additional Information Contact IMSB 763-3562
3
0
The Moscow Internship
Program
Experience Russia Firsthand
For program details complete the coupon below and mail it to:
Boston University International Programs
232 Bay State Road, Box R, Boston, MA 02215 - 617/353-9888
An equal opporunity affim"rive action in"tit"tion
Each Focus Group is limited to 10 participants.
Please call 764-0446 to reserve your spot.
0
0
rj
I
Contraceptive Injection
(sterile medroxyprogesterone acetate suspension, USP)
WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intra-
muscular injection (a shot) in the buttock or upper arm once every 3 months. To continue
your contraceptive protection, you must return for your next injection promptly at the end of
3 months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to
(but not the same as) the natural hormone progesterone, which is produced by your ovaries
during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your
egg cells from ripening. If an egg is not released from the ovaries during your menstrual
cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA also
causes changes in the lining of your uterus that make it less likely for pregnancy to occur.
HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth
control available. This means that the average annual pregnancy rate is less than one for
every 100 women who use DEPO-PROVE RA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness
of DEPO-PROVERA depends only on the patient returning every 3 months for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other con-
traceptive methods and give you the information you need in order to decide which contra-
ceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different
kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the
rate expected in women who use each method exactly as it should be used) and the typical
rate of pregnancy (which includes women who became pregnant because they forgot to
use their birth control or because they did not follow the directions exactly).
PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY
IN THE FIRST YEAR OF CONTINUOUS USE
Lowest
Method Expected Typical
DEPO-PROVERA 0.3 0.3
Implants (Norplant") 0.3 0.3
Female sterilization 0.2 0.4
Male sterilization 0.1 0.15
Oral contraceptive (pill) 3
Combined 0.1-
Progestogen only 0.5 -
IUD 3
Progestasert 2.0--
Copper T 380A 0.8-
Condom (without spermicide) 2 12
Diaphragm (with spermicide) 6 18
Cervical Cap 6 18
Withdrawal 4 18
Periodic abstinence 1 - 9 20
Spermicide alone 3 21
Vaginal Sponge
Used before childbirth 6 18
Used after childbirth 9 28
No method 85 85
Source: Trussell et al; Obstet Gyncol 76:558, 1990
occur and, therefore, the bleeding that comes with your normal menstruation does not take
place. When you stop using DEPO-PROVERA your menstrual period will usually, in time,
return to its normal cycle.
2. Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral
stored in your bones. This could increase your risk of developing bone fractures. The rate
of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it
begins to resemble the normal rate of age-related bone mineral loss.
3. Cancer
Studies of women who have used different forms of contraception found that women who
used DEPO-PROVERA for contraception had no increasedoverall risk of developing cancer
of the breast, ovary, uterus, cervix, or liver. However, women under 35 years of age whose
first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly
increased risk of developing breast cancer similar to that seen with oral contraceptives.
You should discuss this with your health-care provider.
4. Accidental Pregnancy
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
pregnancy for women who get their shots regularly (every 3 months) is very low. While there
have been reports of an increased risk of low birth weight and neonatal infant death or
other health problems in infants conceived close to the time of injection, such pregnancies
are rare. If you think you may have become pregnant while using DEPO-PROVERA for con-
traception, see your health-care provider as soon as possible.
5. Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots
or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg
will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare,
youtshould tell your health-care provider if you have any of the problems listed in the next
section.
WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-POVERA
CONTRACEPTIVE INJECTION?
Call your health-care provider immediately if any of these problems occur following an
injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness of
breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi-
ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm
or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible
clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness in the lower
abdominai area; or persistent pain, pus, or bleeding at the injection site.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds
of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5
pounds during the first year of use. You may continue to gain weight after the first year.
Women in one large study who used DEPO-PROVERA for 2 years gained an average total
of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin-
ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate-
ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5
pounds over those 6 years, or approximately 2.75 pounds per year.
2. Other Side Effects
In a clinical study of over,3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness,
abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps,
nausea, vaginal discharge or irritation, breast swelling and tendemess, bloating, swelling of
the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or
excessive hair loss, rash, and hot flashes. Other problems were reported by very few of the
women in the clinical trials, but some of these could be serious. These include convulsions,
jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of
return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can-
cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss
them with your health-care provider.
SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period,
or your periods may stop completely. If you have been receiving your DEPO-PROVERA
injections regularly every 3 months, then you are probably not pregnant. However, if you
think that you may be pregnant, see your health-care provider.
2. Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are
using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones
such as DEPO-PROVERA.
3. Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
rq
W
0
0
MOSCOW ST. PETERSBURG MOSCOW
I would like to receive more information on your
Moscow Internship Program.
I am interested in a semester.. .-or a summer- Moscow Internship Program.
Name
Street
City
Phone (
State
College or University
Current Status: 0 Fr
Zip
Q So 0 Jr 0 Sr If you prefer, call 617/353-9888.
R
Y I
0l
WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION?
Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you
think you might be pregnant, have any vaginal bleeding without a known reason, have
had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in
your legs, have problems with your liver or liver disease, or are allergic to DEPO-
PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a
physical examination before your doctor prescribes DEPO-PROVERA. It is important to
tell your doctor if you are taking any prescription or over-the-counter medications or if
you have a family history of breast cancer; an abnormal mammogram (breast x-ray),
fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney
disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches;
asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a
history of depression.
I
I